- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02184949
Exploring the Volume-Outcome Relationship for PCI Procedures Undertaken in a UK Context: A NICOR Study
May 1, 2018 updated by: Dara O'Neill, University College, London
Percutaneous Coronary Interventions in the UK: The Relationship Between Procedural Volumes and Patient Outcomes in a Changing Context (A NICOR Study)
The relationship between annual procedural volume and patient outcome remains a debated issue in the field of interventional medicine.
An under-explored issue in a UK context is whether or not such a relationship exists for percutaneous coronary interventions (PCI).
In recent years, this procedure has replaced thrombolysis as the standard intervention method used in UK hospitals for widening patients' obstructed coronary arteries.
However, the actual number of such procedures currently undertaken annually remains variable across hospitals where these interventions are performed.
The UK's National Institute for Health and Care Excellence has consequently called for research into whether such differences in volume play any role in patient outcome for this particular procedure.
The current study is intended to address that research need, and will do so by looking at whether the annual number of PCI procedures undertaken by individual hospitals is predictive of patient mortality post-procedure.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Using data collected as part of a UK national audit of percutaneous coronary interventions, this study will:
- Establish whether annual hospital volume is a clinically important novel risk factor for 30-day mortality post-PCI when examined relative to a newly developed risk model intended for use in clinical practice.
- Establish whether the nature of this volume-outcome relationship is best fit as a linear or non-linear model.
- Establish whether annual hospital volume is a clinically important novel risk factor for 30-day mortality post-primary PCI when examined relative to a newly developed risk model intended for use in clinical practice.
Study Type
Observational
Enrollment (Actual)
427467
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
London, United Kingdom, WC1E 6BT
- University College London
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Percutaneous coronary interventions undertaken in UK hospitals are recorded in the UK National Audit of Percutaneous Coronary Intervention.
Patients who contribute data to this audit will be eligible for inclusion in this study.
Additional inclusion criteria, as described below, will be applied to ensure that data are appropriate for the intended analysis.
Description
Inclusion Criteria:
- are aged between 18 and 100 (inclusive) on the date of their procedure;
- do not have pre-operative ventilation;
- undergo a PCI procedure in a UK hospital that contributes data to the National Audit of Percutaneous Coronary Intervention; and
- have a tracked mortality status at 30 days' post-procedure.
To account for potential dependencies in the data, patients' non-index (i.e. follow-up) PCI procedures occurring during the data collection period will be excluded from the study sample.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Primary Sample
All percutaneous coronary intervention patients who meet the primary eligibility criteria for this study.
|
Other Names:
|
Subsample
Patients drawn from the main sample who specifically underwent a primary percutaneous coronary intervention procedure.
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
All-cause mortality
Time Frame: 30 days post-procedure
|
30 days post-procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: D O'Neill, PhD, University College, London
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2014
Primary Completion (Actual)
December 1, 2014
Study Completion (Actual)
April 1, 2015
Study Registration Dates
First Submitted
July 3, 2014
First Submitted That Met QC Criteria
July 3, 2014
First Posted (Estimate)
July 9, 2014
Study Record Updates
Last Update Posted (Actual)
May 4, 2018
Last Update Submitted That Met QC Criteria
May 1, 2018
Last Verified
May 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- NICOR-PCI-VolOut
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Percutaneous Coronary Intervention
-
Ospedale della MisericordiaUnknownTo Achieve an Early Reendothelialization at the Expense of Low Restenosis: The EREMUS Study (EREMUS)Percutaneous Coronary Intervention | Angioplasty, Transluminal, Percutaneous CoronaryItaly
-
Asan Medical CenterLN RoboticsRecruitingPercutaneous Coronary InterventionKorea, Republic of
-
Portola PharmaceuticalsCompletedPercutaneous Coronary InterventionUnited States, Austria, Canada, Germany, Poland
-
Shiraz University of Medical SciencesBaqiyatallah university of medical sciencesCompletedPercutaneous Coronary Intervention
-
Corindus Inc.Completed
-
University of GroningenAbbottUnknownPercutaneous Coronary InterventionNetherlands
-
Stiftung Institut fuer HerzinfarktforschungCompletedPercutaneous Coronary InterventionGermany
-
Beijing Anzhen HospitalUnknownPercutaneous Coronary InterventionChina
-
SanofiCompletedPercutaneous Coronary Intervention
-
University Hospital of FerraraCompletedPercutaneous Coronary Intervention | Coronary PhysiologyItaly
Clinical Trials on Percutaneous Coronary Intervention
-
Mid and South Essex NHS Foundation TrustImperial College LondonRecruitingStable Angina | Chronic Total Occlusion of Coronary ArteryUnited Kingdom
-
Nanjing First Hospital, Nanjing Medical UniversityCompletedCoronary Artery DiseaseChina
-
University Hospital, SaarlandCompletedAcute Myocardial InfarctionGermany
-
University Hospital of PatrasCompletedCoronary Artery Bypass SurgeryGreece
-
Yonsei UniversityUnknownCoronary Artery Disease | Stable Angina | Unstable AnginaKorea, Republic of
-
RobocathCompletedCoronary Artery Disease | Percutaneous Coronary InterventionFrance, Belgium, Luxembourg, Netherlands
-
ECRI bvBoston Scientific Corporation; Philips HealthcareActive, not recruitingLeft Main Coronary Artery StenosisSpain, United Kingdom, Italy
-
Herlev and Gentofte HospitalUnknownCoronary Heart Disease | Ischemic Heart Disease | Stable AnginaDenmark
-
Niels Ramsing HolmJohnson & JohnsonUnknown
-
Corindus Inc.CompletedMyocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Vascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Arterial Occlusive DiseasesUnited States, Israel